Merck & Co Inc (MRK)
127.51
-0.75
(-0.58%)
USD |
NYSE |
May 03, 16:00
127.59
+0.08
(+0.06%)
Pre-Market: 20:00
Merck Research and Development Expense (TTM): 30.25B for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 30.25B |
December 31, 2023 | 30.53B |
September 30, 2023 | 24.68B |
June 30, 2023 | 25.77B |
March 31, 2023 | 15.25B |
December 31, 2022 | 13.55B |
September 30, 2022 | 12.84B |
June 30, 2022 | 10.89B |
March 31, 2022 | 12.41B |
December 31, 2021 | 12.25B |
September 30, 2021 | 14.97B |
June 30, 2021 | 15.87B |
March 31, 2021 | 13.63B |
December 31, 2020 | 13.43B |
September 30, 2020 | 10.04B |
June 30, 2020 | 9.898B |
March 31, 2020 | 10.00B |
December 31, 2019 | 9.724B |
September 30, 2019 | 9.538B |
June 30, 2019 | 8.402B |
March 31, 2019 | 8.487B |
December 31, 2018 | 9.752B |
September 30, 2018 | 9.853B |
June 30, 2018 | 12.20B |
March 31, 2018 | 11.71B |
Date | Value |
---|---|
December 31, 2017 | 10.34B |
September 30, 2017 | 12.81B |
June 30, 2017 | 10.06B |
March 31, 2017 | 10.43B |
December 31, 2016 | 10.26B |
September 30, 2016 | 7.272B |
June 30, 2016 | 7.108B |
March 31, 2016 | 6.627B |
December 31, 2015 | 6.705B |
September 30, 2015 | 7.19B |
June 30, 2015 | 7.349B |
March 31, 2015 | 7.343B |
December 31, 2014 | 7.18B |
September 30, 2014 | 6.732B |
June 30, 2014 | 6.733B |
March 31, 2014 | 7.17B |
December 31, 2013 | 7.503B |
September 30, 2013 | 7.892B |
June 30, 2013 | 8.15B |
March 31, 2013 | 8.214B |
December 31, 2012 | 8.169B |
September 30, 2012 | 8.364B |
June 30, 2012 | 8.40B |
March 31, 2012 | 8.171B |
December 31, 2011 | 8.467B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
8.402B
Minimum
Jun 2019
30.53B
Maximum
Dec 2023
15.20B
Average
13.14B
Median
Research and Development Expense (TTM) Benchmarks
Amgen Inc | 5.069B |
Johnson & Johnson | 15.30B |
Eli Lilly and Co | 9.851B |
Pfizer Inc | 10.67B |
Moderna Inc | 4.777B |